Press release
Pharmacogenetic Testing Market Overview, Current Trends, and Key Player Analysis
Pharmacogenetic Testing Market
Pharmacogenetic Testing Market Size and Growth Outlook Through 2030
The pharmacogenetic testing market is projected to grow significantly, reaching a market size of $29.55 billion by 2030. This expansion corresponds to a compound annual growth rate (CAGR) of 15.5%. The forecasted growth is fueled by several critical factors, including the advancement of precision healthcare, the broadening availability of direct-to-consumer testing, increased integration with electronic health records, stronger regulatory support, and heightened investments in genomics research. Key trends influencing the market include the rising adoption of personalized medicine, expanded use of genetic testing for drug selection, growth in oncology and cardiology applications, heightened demand for precision diagnostics, and greater incorporation of pharmacogenomics into clinical practice.
Download a free sample of the pharmacogenetic testing market sample:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19139&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Leading Companies Shaping the Pharmacogenetic Testing Industry
Several prominent companies dominate the pharmacogenetic testing landscape. These include CVS Health Corporation, Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, Eurofins Scientific Inc., Bio-Rad Laboratories, Precision Medicine Advisors, Azenta Life Sciences, Fulgent Genetics, Pacific Biosciences of California Inc., Castle Biosciences, 23andMe Holding Co., Helix Inc., Genomind Inc., MD Labs, Sonic Genetics, AutoGenomics Inc., LabClinics SA, Gene By Gene Ltd., Xcode Life Sciences, YouScript, and RxGenomix LLC.
A noteworthy development occurred in May 2023 when HealthOme, a US-based company specializing in genetic testing and personalized medicine solutions, acquired Kailos Genetics. This acquisition, for an undisclosed amount, bolstered HealthOme's personalized medicine offerings by incorporating Kailos Genetics' advanced genomic technologies and pharmacogenetic testing capabilities. Kailos Genetics, known for its Inspexion platform, provides pharmacogenetic services that enhance HealthOme's ability to offer comprehensive precision-testing solutions with deeper genomic insights.
Key Trends Enhancing Growth in the Pharmacogenetic Testing Market
Market leaders are concentrating on advancing pharmacogenomics testing services, particularly prescription-based pharmacogenetic testing, to improve drug safety and treatment accuracy. Prescription-based testing involves genetic assessments ordered by licensed healthcare providers to understand how an individual's genetic profile affects their response to specific medications. This approach aids clinicians in tailoring drug selection and dosage, thereby reducing adverse drug reactions.
For example, in May 2023, UCSF, a US healthcare organization, introduced a pharmacogenomics testing service aimed at refining treatment precision. This service equips healthcare professionals with genetic information to customize drug therapies for each patient, enhancing treatment effectiveness and minimizing potential side effects.
View the full pharmacogenetic testing market report:
https://www.thebusinessresearchcompany.com/report/pharmacogenetic-testing-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Detailed Segmentation of the Pharmacogenetic Testing Market
The pharmacogenetic testing market is comprehensively segmented into several categories:
1) By Type:
- Whole Genome Sequencing
- Whole Exome Sequencing
- Array-Based Tests
- Single Gene Tests
2) By Drug Type:
- Prescription Drugs
- Nutraceuticals
- Recreational Drugs
- Herbal Supplements
- Vitamins
- Over-The-Counter Medications
3) By Therapeutic Area:
- Cardiology
- Gastroenterology
- Anesthesiology
- Genomics
- Endocrinology
- Immunology and Hypersensitivity
- Dermatology
- Gynecology
- Oncology
- Other Therapeutic Areas
4) By Distribution Channel:
- Hospital Pharmacy
- Retail Pharmacies
- Mail-Order Pharmacies
- Direct-to-Customer Services
5) By End User:
- Healthcare Providers
- Pharmaceutical and Biotechnology Companies
- Centers and Academic Institutes
- Other End Users
Further subcategories include:
- Whole Genome Sequencing by platforms such as Illumina Sequencing, Ion Torrent Sequencing, Pacific Biosciences Sequencing, and Oxford Nanopore Sequencing
- Whole Exome Sequencing divided into Capture-Based, Targeted Enrichment, and Hybridization-Based methods
- Array-Based Tests including SNP Array, Expression Array, and Copy Number Variation Array Testing
- Single Gene Tests comprising Targeted Gene Panels, Mutation Detection Tests, and Sequencing of Specific Genes
This detailed segmentation offers a clear framework for analyzing the diverse aspects of the pharmacogenetic testing market and understanding how various components contribute to its overall growth and development.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pharmacogenetic Testing Market Overview, Current Trends, and Key Player Analysis here
News-ID: 4499811 • Views: …
More Releases from The Business Research Company
Growth Patterns, Market Segmentation, and Competitive Approaches Influencing the …
The nebivolol tablets market is poised for significant expansion as demand for effective cardiovascular treatments continues to rise. With ongoing advancements in formulations and growing patient awareness, this sector is set to experience steady growth through 2030. Let's explore the projected market size, driving forces, emerging players, key trends, and segmentation within the nebivolol tablets industry.
Projected Growth and Market Size of Nebivolol Tablets by 2030
The nebivolol tablets market…
Market Segmentation, Major Trends, and Competitive Analysis of the Natural Baby …
The natural baby body massage oil market is set for notable expansion over the coming years, driven by a combination of consumer preferences and industry innovations. As parents increasingly seek safe, organic options for infant care, the market is responding with diverse product offerings and enhanced formulations. Let's explore the current market size, leading companies, trends shaping growth, and key segments defining this evolving landscape.
Growth Outlook and Market Size for…
Leading Companies Enhancing Their Presence in the Nanotechnology-Based Medical D …
Nanotechnology is rapidly transforming the medical devices field, promising groundbreaking innovations and enhanced patient care. As this technology continues to evolve, the market for nanotechnology-based medical devices is set to expand at an impressive pace. Let's explore the anticipated market growth, major players involved, emerging trends, and key segments shaping this exciting industry.
Nanotechnology-Based Medical Devices Market Size and Growth Outlook
The market for nanotechnology-based medical devices is projected to…
Competitive Landscape: Key Market Leaders and New Entrants in the Phenobarbital …
The phenobarbital market is positioned for steady expansion over the coming years, driven by several key factors and evolving trends. As demand continues to rise, especially in resource-limited settings, this market is expected to witness notable growth supported by advances in manufacturing and increasing clinical applications.
Forecasting the Phenobarbital Market Size through 2030
The value of the phenobarbital market is projected to reach $1.96 billion by 2030, growing at a…
More Releases for Gene
DNA and Gene Cloning Services Market Expands with Growing Focus on Complex Gene …
InsightAce Analytic Pvt. Ltd. has announced the publication of a market research report titled "Global DNA and Gene Cloning Services Market by Type of Service Offered (Custom Cloning, Sub-cloning, Gene Synthesis, and Others), Type of Gene (Complex Gene, Standard Gene, and Others), End-User Industry (Pharmaceutical, Academic and R&D, and Biotechnology Companies, and Others)- Market Outlook and Industry Analysis 2034"
The DNA and Gene Cloning Services Market Size is valued…
Evolving Market Trends In The CRISPR Gene Editing Industry: Innovative Gene Ther …
The CRISPR Gene Editing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected CRISPR Gene Editing Market Size During the Forecast Period?
The CRISPR gene editing market has grown exponentially in recent years. It will grow from $2.26 billion in 2024 to $2.88…
Cell and Gene Therapy Market Global Analysis By Type (Cell Therapy, Gene Therapy …
Gene and cell therapy uses genes and cells for the treatment of genetic diseases. Genetic diseases are caused by mutations, or errors in genes which can be passed down from one generation to another. Gene therapy aims to treat diseases by using genetic material, or DNA, to manipulate a patient's cells by replacing, changing or introducing genome into cells- either internally or externally. Cell therapy aims to treat diseases by…
Competitive and Opportunities Analysis of Gene Therapy Market of Gene Therapy Ma …
Global Gene Therapy Market accounted for US$ 2.05 billion in 2020 and is estimated to be US$ 12.29 billion by 2030 and is anticipated to register a CAGR of 19.8%. Gene therapy means fixing a working gene to an individual who features a damaged gene. The European Commission has approved this method for one particular treatment. The treatment by the merchandise Glybera uses an epidemic to infect muscle cells with…
Genetic Testing Market Size by Growth Opportunities, Top Key Players: GeneDx, In …
Genetic Testing Market Report provides an in-depth analysis of the overall market, The ripple effect of Coronavirus-Covid19 on the market needs to become part of strategy discussions to emerge strong. The report focuses on major key players, production details, their application, countries and also analyzes the global and key regions market potential and advantage, opportunity, and challenge, restraints, and risks.
The Top players Covered in report are GeneDx, Invitae, Pathway Genomics,…
Gene Synthesis Market by Top Manufacturers - Gene script, Gene Art (Thermofische …
The "Gene Synthesis Market" report Added by "Big Market Research", enumerates information about the industry in terms of market share, market size, revenue forecasts, and regional outlook. The report further illustrates competitive insights of key players in the business vertical followed by an overview of their diverse portfolios and growth strategies.
In the Gene Synthesis Market 2018 research report professionals describe the different facets of the industry with a specific goal…
